Clinical trial studies help doctors and researchers find better ways to prevent, treat or diagnose diseases. There are several types of cancer clinical trials — some test new ways to treat cancer; others test new methods of prevention, detection or diagnosis.
Clinical trials follow a plan known as a protocol. The protocol is carefully designed to balance the potential benefits and risks to participants and answer specific research questions. A protocol describes the following:
The goal of the study
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help scientists answer different questions.
Current trials offered at Hunterdon Regional Cancer Center include new treatment protocols conducted by pharmaceutical companies and The National Institute of Health (Cooperative Group Trials).
Current trials may include treatment options for breast, colon, prostate or lung cancers, as well as, treatment options for gynecological, leukemia, lymphomas, melanoma, and hematologic conditions.
To learn more about participation in current clinical trials with Hunterdon Regional Cancer Center, please contact Deborah Brunetti, Clinical Research Coordinator, at 908-237-2330 ext. 3 or visit Hunterdon Hematology Oncology.
Summary: Randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
To learn more about available clinical research trials contact:
Deborah Brunetti, RN, CRC
Hunterdon Regional Cancer Center – Research Department
2100 Wescott Drive, Flemington, NJ 08822
908-237-2330 option #3
A Twice Monthly E-Newsletter